NanoViricides (NNVC) news
Recent news
Nanoviricides, Inc: Noble Capital initiates coverage with outperform rating; target price $6
On July 6, 2026, Noble Capital initiated coverage on NanoViricides, Inc. (NNVC) with an "outperform" rating and a target price of $6 per share. This move comes amid ongoing analysis of the company’s stock performance and market positioning. The AI-powered evaluation of NNVC indicates a strong…
AInvest Wire · Jul 6, 2026NanoViricides files to offer up to $50 million in securities - SEC filing
NanoViricides, Inc. (NYSE American: NNVC) has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) that allows for the potential offering of up to $50 million in securities, according to a recent SEC filing. The registration statement, filed under Form S-3 (File No.…
AInvest Wire · Jun 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.